 | • レポートコード：GIR-107A14919 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗レトロウイルス薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗レトロウイルス薬の種類別市場規模（マルチクラス併用薬、NRTI、NNRTI、プロテアーゼ阻害剤、その他）、用途別市場規模（病院、製薬会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗レトロウイルス薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、ViiV Healthcare、Bristol-Myer Squibb、AbbVie、Boehringer-Ingelheim、Johnson and Johnson、Merck、CIPLA ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：マルチクラス併用薬、NRTI、NNRTI、プロテアーゼ阻害剤、その他 ・用途別分析2016年-2026年：病院、製薬会社、その他 ・抗レトロウイルス薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗レトロウイルス薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗レトロウイルス薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗レトロウイルス薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗レトロウイルス薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antiretroviral Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antiretroviral Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Antiretroviral Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antiretroviral Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Multi-Class Drugs Combination
NRTI
NNRTI
Protease Inhibitors
Other
Market segment by Application, can be divided into
Hospital
Pharmaceutical Companies
Other
Market segment by players, this report covers
Gilead Sciences
ViiV Healthcare
Bristol-Myer Squibb
AbbVie
Boehringer-Ingelheim
Johnson and Johnson
Merck
CIPLA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Antiretroviral Drug
1.2 Classification of Antiretroviral Drug by Type
1.2.1 Overview: Global Antiretroviral Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Antiretroviral Drug Revenue Market Share by Type in 2020
1.2.3 Multi-Class Drugs Combination
1.2.4 NRTI
1.2.5 NNRTI
1.2.6 Protease Inhibitors
1.2.7 Other
1.3 Global Antiretroviral Drug Market by Application
1.3.1 Overview: Global Antiretroviral Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Antiretroviral Drug Market Size & Forecast
1.5 Global Antiretroviral Drug Market Size and Forecast by Region
1.5.1 Global Antiretroviral Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Antiretroviral Drug Market Size by Region, (2016-2021)
1.5.3 North America Antiretroviral Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Antiretroviral Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Antiretroviral Drug Market Size and Prospect (2016-2026)
1.5.6 South America Antiretroviral Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Antiretroviral Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiretroviral Drug Market Drivers
1.6.2 Antiretroviral Drug Market Restraints
1.6.3 Antiretroviral Drug Trends Analysis
2 Company Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Antiretroviral Drug Product and Solutions
2.1.4 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Gilead Sciences Recent Developments and Future Plans
2.2 ViiV Healthcare
2.2.1 ViiV Healthcare Details
2.2.2 ViiV Healthcare Major Business
2.2.3 ViiV Healthcare Antiretroviral Drug Product and Solutions
2.2.4 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 ViiV Healthcare Recent Developments and Future Plans
2.3 Bristol-Myer Squibb
2.3.1 Bristol-Myer Squibb Details
2.3.2 Bristol-Myer Squibb Major Business
2.3.3 Bristol-Myer Squibb Antiretroviral Drug Product and Solutions
2.3.4 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol-Myer Squibb Recent Developments and Future Plans
2.4 AbbVie
2.4.1 AbbVie Details
2.4.2 AbbVie Major Business
2.4.3 AbbVie Antiretroviral Drug Product and Solutions
2.4.4 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AbbVie Recent Developments and Future Plans
2.5 Boehringer-Ingelheim
2.5.1 Boehringer-Ingelheim Details
2.5.2 Boehringer-Ingelheim Major Business
2.5.3 Boehringer-Ingelheim Antiretroviral Drug Product and Solutions
2.5.4 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Boehringer-Ingelheim Recent Developments and Future Plans
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business
2.6.3 Johnson and Johnson Antiretroviral Drug Product and Solutions
2.6.4 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson and Johnson Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Antiretroviral Drug Product and Solutions
2.7.4 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 CIPLA
2.8.1 CIPLA Details
2.8.2 CIPLA Major Business
2.8.3 CIPLA Antiretroviral Drug Product and Solutions
2.8.4 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 CIPLA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antiretroviral Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Antiretroviral Drug Players Market Share
3.2.2 Top 10 Antiretroviral Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Antiretroviral Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antiretroviral Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Antiretroviral Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Antiretroviral Drug Revenue Market Share by Application (2016-2021)
5.2 Antiretroviral Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Antiretroviral Drug Revenue by Type (2016-2026)
6.2 North America Antiretroviral Drug Revenue by Application (2016-2026)
6.3 North America Antiretroviral Drug Market Size by Country
6.3.1 North America Antiretroviral Drug Revenue by Country (2016-2026)
6.3.2 United States Antiretroviral Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Antiretroviral Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Antiretroviral Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Antiretroviral Drug Revenue by Type (2016-2026)
7.2 Europe Antiretroviral Drug Revenue by Application (2016-2026)
7.3 Europe Antiretroviral Drug Market Size by Country
7.3.1 Europe Antiretroviral Drug Revenue by Country (2016-2026)
7.3.2 Germany Antiretroviral Drug Market Size and Forecast (2016-2026)
7.3.3 France Antiretroviral Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Antiretroviral Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Antiretroviral Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Antiretroviral Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antiretroviral Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Antiretroviral Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Antiretroviral Drug Market Size by Region
8.3.1 Asia-Pacific Antiretroviral Drug Revenue by Region (2016-2026)
8.3.2 China Antiretroviral Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Antiretroviral Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Antiretroviral Drug Market Size and Forecast (2016-2026)
8.3.5 India Antiretroviral Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Antiretroviral Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Antiretroviral Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Antiretroviral Drug Revenue by Type (2016-2026)
9.2 South America Antiretroviral Drug Revenue by Application (2016-2026)
9.3 South America Antiretroviral Drug Market Size by Country
9.3.1 South America Antiretroviral Drug Revenue by Country (2016-2026)
9.3.2 Brazil Antiretroviral Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Antiretroviral Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antiretroviral Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Antiretroviral Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Antiretroviral Drug Market Size by Country
10.3.1 Middle East & Africa Antiretroviral Drug Revenue by Country (2016-2026)
10.3.2 Turkey Antiretroviral Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Antiretroviral Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Antiretroviral Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Antiretroviral Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Antiretroviral Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Antiretroviral Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Antiretroviral Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Antiretroviral Drug Revenue Market Share by Region (2021-2026)
Table 6. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 7. Gilead Sciences Major Business
Table 8. Gilead Sciences Antiretroviral Drug Product and Solutions
Table 9. Gilead Sciences Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. ViiV Healthcare Corporate Information, Head Office, and Major Competitors
Table 11. ViiV Healthcare Major Business
Table 12. ViiV Healthcare Antiretroviral Drug Product and Solutions
Table 13. ViiV Healthcare Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol-Myer Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol-Myer Squibb Major Business
Table 16. Bristol-Myer Squibb Antiretroviral Drug Product and Solutions
Table 17. Bristol-Myer Squibb Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AbbVie Corporate Information, Head Office, and Major Competitors
Table 19. AbbVie Major Business
Table 20. AbbVie Antiretroviral Drug Product and Solutions
Table 21. AbbVie Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Boehringer-Ingelheim Corporate Information, Head Office, and Major Competitors
Table 23. Boehringer-Ingelheim Major Business
Table 24. Boehringer-Ingelheim Antiretroviral Drug Product and Solutions
Table 25. Boehringer-Ingelheim Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson and Johnson Major Business
Table 28. Johnson and Johnson Antiretroviral Drug Product and Solutions
Table 29. Johnson and Johnson Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Antiretroviral Drug Product and Solutions
Table 33. Merck Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. CIPLA Corporate Information, Head Office, and Major Competitors
Table 35. CIPLA Major Business
Table 36. CIPLA Antiretroviral Drug Product and Solutions
Table 37. CIPLA Antiretroviral Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Antiretroviral Drug Revenue (USD Million) by Players (2019-2021)
Table 39. Global Antiretroviral Drug Revenue Share by Players (2019-2021)
Table 40. Breakdown of Antiretroviral Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Antiretroviral Drug Players Head Office, Products and Services Provided
Table 42. Antiretroviral Drug Mergers & Acquisitions in the Past Five Years
Table 43. Antiretroviral Drug New Entrants and Expansion Plans
Table 44. Global Antiretroviral Drug Revenue (USD Million) by Type (2016-2021)
Table 45. Global Antiretroviral Drug Revenue Share by Type (2016-2021)
Table 46. Global Antiretroviral Drug Revenue Forecast by Type (2021-2026)
Table 47. Global Antiretroviral Drug Revenue by Application (2016-2021)
Table 48. Global Antiretroviral Drug Revenue Forecast by Application (2021-2026)
Table 49. North America Antiretroviral Drug Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Antiretroviral Drug Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Antiretroviral Drug Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Antiretroviral Drug Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Antiretroviral Drug Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Antiretroviral Drug Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Antiretroviral Drug Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Antiretroviral Drug Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Antiretroviral Drug Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Antiretroviral Drug Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Antiretroviral Drug Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Antiretroviral Drug Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Antiretroviral Drug Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Antiretroviral Drug Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Antiretroviral Drug Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Antiretroviral Drug Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Antiretroviral Drug Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Antiretroviral Drug Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Antiretroviral Drug Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Antiretroviral Drug Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Antiretroviral Drug Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Antiretroviral Drug Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Antiretroviral Drug Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Antiretroviral Drug Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Antiretroviral Drug Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Antiretroviral Drug Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Antiretroviral Drug Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Antiretroviral Drug Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Antiretroviral Drug Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Antiretroviral Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Antiretroviral Drug Picture
Figure 2. Global Antiretroviral Drug Revenue Market Share by Type in 2020
Figure 3. Multi-Class Drugs Combination
Figure 4. NRTI
Figure 5. NNRTI
Figure 6. Protease Inhibitors
Figure 7. Other
Figure 8. Antiretroviral Drug Revenue Market Share by Application in 2020
Figure 9. Hospital Picture
Figure 10. Pharmaceutical Companies Picture
Figure 11. Other Picture
Figure 12. Global Antiretroviral Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Antiretroviral Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Antiretroviral Drug Revenue Market Share by Region (2016-2026)
Figure 15. Global Antiretroviral Drug Revenue Market Share by Region in 2020
Figure 16. North America Antiretroviral Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Antiretroviral Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Antiretroviral Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Antiretroviral Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Antiretroviral Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Antiretroviral Drug Market Drivers
Figure 22. Antiretroviral Drug Market Restraints
Figure 23. Antiretroviral Drug Market Trends
Figure 24. Gilead Sciences Recent Developments and Future Plans
Figure 25. ViiV Healthcare Recent Developments and Future Plans
Figure 26. Bristol-Myer Squibb Recent Developments and Future Plans
Figure 27. AbbVie Recent Developments and Future Plans
Figure 28. Boehringer-Ingelheim Recent Developments and Future Plans
Figure 29. Johnson and Johnson Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. CIPLA Recent Developments and Future Plans
Figure 32. Global Antiretroviral Drug Revenue Share by Players in 2020
Figure 33. Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Antiretroviral Drug Revenue Market Share in 2020
Figure 35. Global Top 10 Players Antiretroviral Drug Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Antiretroviral Drug Revenue Share by Type in 2020
Figure 38. Global Antiretroviral Drug Market Share Forecast by Type (2021-2026)
Figure 39. Global Antiretroviral Drug Revenue Share by Application in 2020
Figure 40. Global Antiretroviral Drug Market Share Forecast by Application (2021-2026)
Figure 41. North America Antiretroviral Drug Sales Market Share by Type (2016-2026)
Figure 42. North America Antiretroviral Drug Sales Market Share by Application (2016-2026)
Figure 43. North America Antiretroviral Drug Revenue Market Share by Country (2016-2026)
Figure 44. United States Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Antiretroviral Drug Sales Market Share by Type (2016-2026)
Figure 48. Europe Antiretroviral Drug Sales Market Share by Application (2016-2026)
Figure 49. Europe Antiretroviral Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Antiretroviral Drug Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Antiretroviral Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Antiretroviral Drug Revenue Market Share by Region (2016-2026)
Figure 58. China Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Antiretroviral Drug Sales Market Share by Type (2016-2026)
Figure 65. South America Antiretroviral Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Antiretroviral Drug Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Antiretroviral Drug Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Antiretroviral Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Antiretroviral Drug Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Antiretroviral Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…- 世界のNSCLC用標的薬VEGFR2阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug VEGFR2 Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のNSCLC用標的薬BRAF阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug BRAF Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のスニチニブ薬市場 2021：企業別、地域別、種類・用途別 The Sunitinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のNSCLC用標的薬VEGF阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug VEGF Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…